Press Releases

PRESS RELEASES - year 2025

Alivus Life Sciences Reports Strong Q3FY25 Results, Delivers 12%…

Glenmark Life Sciences rebrands as Alivus Life Sciences…

Glenmark Life Sciences reports revenue of Rs. 5,069 Mn for Q2FY25, Gross margins of 55.6%, up…

Glenmark Life Sciences reports revenue growth of 9.7% QoQ for Q1FY25, EBITDA margins of 28%, up…

Glenmark Life Sciences reports revenue growth of 5.6%, EBITDA margins of 30.1% in FY24

Nirma Limited acquires majority stake in Glenmark Life Sciences

Glenmark Life Sciences reports quality revenue growth of 5.9% YoY Delivers robust EBITDA growth

Glenmark Life Sciences announces another CDMO deal

Glenmark Life Sciences Strong Growth Momentum Continues, Revenue Surges 17% YoY…

Glenmark Life Sciences maintains strong growth momentum, reports robust 25% EBITDA growth in…

Glenmark Life Sciences sustains strong growth momentum in Q4FY23

Revenue growth of 6% QoQ Strong growth in India, Europe and LATAM with recovery in US business

Revenue growth of 4% QoQ Regulated markets led the growth

PAT growth of 7.7% YoY for Q1 FY23 CVS and CNS therapies lead the growth of the generic API

Glenmark Life Sciences reports revenue growth of 10% YoY for Q4 FY22; 12.6% for the full year, FY22

Glenmark Life Sciences reports revenue growth of 4.5% and PAT growth of 11.1% YoY for Q3 FY22

Glenmark Life Sciences reports revenue growth of 7.9% and PAT growth of 59.0% YoY for Q2 FY22…

Glenmark Life Sciences reports revenue growth of 32.2% and PAT growth of 24.5% YoY for Q1 FY22

Glenmark Appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its…